![NDX NDX](https://data.pdbj.org/pdbjplus/data/cc/svg/NDX.svg) | NDX | Name: | [[(2~{R},3~{S},4~{R},5~{R})-5-[4-[(1~{S},3~{a}~{S},3~{b}~{S},5~{a}~{R},8~{S},9~{a}~{R},9~{b}~{S},11~{a}~{S})-1-(~{tert}-butylcarbamoyl)-9~{a},11~{a}-dimethyl-7-oxidanylidene-1,2,3,3~{a},3~{b},4,5,5~{a},6,8,9,9~{b},10,11-tetradecahydroindeno[5,4-f]quinolin-8-yl]-3-aminocarbonyl-4~{H}-pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methyl hydrogen phosphate | Formula: | C44 H66 N9 O19 P3 | SMILES: | CC(C)(C)NC(=O)[CH]1CC[CH]2[CH]3CC[CH]4NC(=O)[CH](C[C]4(C)[CH]3CC[C]12C)[CH]5C=CN(C=C5C(N)=O)[CH]6O[CH](CO[P](O)(=O)O[P](O)(=O)OC[CH]7O[CH]([CH](O[P](O)(O)=O)[CH]7O)n8cnc9c(N)ncnc89)[CH](O)[CH]6O | InChi: | InChI=1S/C44H66N9O19P3/c1-42(2,3)51-39(59)26-8-7-24-21-6-9-29-44(5,25(21)10-12-43(24,26)4)14-22(38(58)50-29)20-11-13-52(15-23(20)36(46)57)40-33(56)31(54)27(69-40)16-67-74(63,64)72-75(65,66)68-17-28-32(55)34(71-73(60,61)62)41(70-28)53-19-49-30-35(45)47-18-48-37(30)53/h11,13,15,18-22,24-29,31-34,40-41,54-56H,6-10,12,14,16-17H2,1-5H3,(H2,46,57)(H,50,58)(H,51,59)(H,63,64)(H,65,66)(H2,45,47,48)(H2,60,61,62)/t20-,21+,22+,24+,25+,26-,27-,28-,29-,31-,32-,33-,34-,40-,41-,43+,44-/m1/s1 | Definition date: | 2020-04-15 | Last modified: | 2020-07-31 | Release date: | 2020-08-05 | Identifier: | [[(2~{R},3~{S},4~{R},5~{R})-5-[4-[(1~{S},3~{a}~{S},3~{b}~{S},5~{a}~{R},8~{S},9~{a}~{R},9~{b}~{S},11~{a}~{S})-1-(~{tert}-butylcarbamoyl)-9~{a},11~{a}-dimethyl-7-oxidanylidene-1,2,3,3~{a},3~{b},4,5,5~{a},6,8,9,9~{b},10,11-tetradecahydroindeno[5,4-f]quinolin-8-yl]-3-aminocarbonyl-4~{H}-pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methyl hydrogen phosphate |
|
![NU2 NU2](https://data.pdbj.org/pdbjplus/data/cc/svg/NU2.svg) | NU2 | Name: | (3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione | Formula: | C27 H34 N4 O5 | SMILES: | CC[CH](C)[CH]1N([CH](C(=O)N2CCOCC2)c3coc(C)n3)C(=O)[CH](NC1=O)C4Cc5ccccc5C4 | InChi: | InChI=1S/C27H34N4O5/c1-4-16(2)23-25(32)29-22(20-13-18-7-5-6-8-19(18)14-20)26(33)31(23)24(21-15-36-17(3)28-21)27(34)30-9-11-35-12-10-30/h5-8,15-16,20,22-24H,4,9-14H2,1-3H3,(H,29,32)/t16-,22+,23+,24+/m0/s1 | Definition date: | 2019-12-13 | Last modified: | 2020-07-31 | Release date: | 2020-08-05 | Identifier: | (3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione |
|
![P7S P7S](https://data.pdbj.org/pdbjplus/data/cc/svg/P7S.svg) | P7S | Name: | N-(4-amino-3-chlorobenzene-1-carbonyl)-3-methyl-L-valyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-prolinamide | Formula: | C22 H29 Cl N4 O6 | SMILES: | C2CN(C(C(C(C)(C)C)NC(c1ccc(c(c1)Cl)N)=O)=O)C(C(NC(CC(=O)O)C=O)=O)C2 | InChi: | InChI=1S/C22H29ClN4O6/c1-22(2,3)18(26-19(31)12-6-7-15(24)14(23)9-12)21(33)27-8-4-5-16(27)20(32)25-13(11-28)10-17(29)30/h6-7,9,11,13,16,18H,4-5,8,10,24H2,1-3H3,(H,25,32)(H,26,31)(H,29,30)/t13-,16-,18+/m0/s1 | Definition date: | 2019-08-06 | Last modified: | 2020-07-31 | Release date: | 2020-08-05 | Identifier: | N-(4-amino-3-chlorobenzene-1-carbonyl)-3-methyl-L-valyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-prolinamide |
|
![QL8 QL8](https://data.pdbj.org/pdbjplus/data/cc/svg/QL8.svg) | QL8 | Name: | 2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]-5-[3-[4-[3-[2-[2-[2-[2-[2-[3-[[(2~{S})-3,3-dimethyl-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]-4-oxidanyl-pyrrolidin-1-yl]-1-oxidanylidene-butan-2-yl]amino]-3-oxidanylidene-propoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]prop-1-ynyl]phenoxy]propyl]-1,3-thiazole-4-carboxylic acid | Formula: | C68 H80 N8 O14 S3 | SMILES: | Cc1ncsc1c2ccc(CNC(=O)[CH]3C[CH](O)CN3C(=O)[CH](NC(=O)CCOCCOCCOCCOCCOCCOCC#Cc4ccc(OCCCc5sc(nc5C(O)=O)N6CCc7cccc(C(=O)Nc8sc9ccccc9n8)c7C6)cc4)C(C)(C)C)cc2 | InChi: | InChI=1S/C68H80N8O14S3/c1-45-60(91-44-70-45)49-20-16-47(17-21-49)41-69-63(80)55-40-50(77)42-76(55)64(81)61(68(2,3)4)72-58(78)25-29-85-31-33-87-35-37-89-39-38-88-36-34-86-32-30-84-27-8-10-46-18-22-51(23-19-46)90-28-9-15-57-59(65(82)83)73-67(93-57)75-26-24-48-11-7-12-52(53(48)43-75)62(79)74-66-71-54-13-5-6-14-56(54)92-66/h5-7,11-14,16-23,44,50,55,61,77H,9,15,24-43H2,1-4H3,(H,69,80)(H,72,78)(H,82,83)(H,71,74,79)/t50-,55+,61-/m1/s1 | Definition date: | 2020-06-24 | Last modified: | 2020-07-31 | Release date: | 2020-08-05 | Identifier: | 2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]-5-[3-[4-[3-[2-[2-[2-[2-[2-[3-[[(2~{S})-3,3-dimethyl-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]-4-oxidanyl-pyrrolidin-1-yl]-1-oxidanylidene-butan-2-yl]amino]-3-oxidanylidene-propoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]prop-1-ynyl]phenoxy]propyl]-1,3-thiazole-4-carboxylic acid |
|
![X4S X4S](https://data.pdbj.org/pdbjplus/data/cc/svg/X4S.svg) | X4S | Name: | beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyr
anose | Formula: | C20 H34 O14 S3 | SMILES: | S(C2COC(SC1C(O)C(O)C(O)OC1)C(O)C2O)C4OCC(SC3OCC(O)C(O)C3O)C(O)C4O | InChi: | InChI=1S/C20H34O14S3/c21-5-1-32-18(14(27)9(5)22)36-7-3-34-20(16(29)11(7)24)37-8-4-33-19(15(28)12(8)25)35-6-2-31-17(30)13(26)10(6)23/h5-30H,1-4H2/t5-,6-,7-,8-,9+,10+,11+,12+,13-,14-,15-,16-,17-,18+,19+,20+/m1/s1 | Synonyms: | thio-linked xylotetraose | Definition date: | 2008-06-18 | Last modified: | 2020-07-17 | Identifier: | beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranose |
|
![X5S X5S](https://data.pdbj.org/pdbjplus/data/cc/svg/X5S.svg) | X5S | Name: | beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyr
anosyl-(1->4)-4-thio-beta-D-xylopyranose | Formula: | C25 H42 O17 S4 | SMILES: | S(C2COC(SC1C(O)C(O)C(O)OC1)C(O)C2O)C5OCC(SC4OCC(SC3OCC(O)C(O)C3O)C(O)C4O)C(O)C5O | InChi: | InChI=1S/C25H42O17S4/c26-6-1-39-22(17(33)11(6)27)44-8-3-41-24(19(35)13(8)29)46-10-5-42-25(20(36)15(10)31)45-9-4-40-23(18(34)14(9)30)43-7-2-38-21(37)16(32)12(7)28/h6-37H,1-5H2/t6-,7-,8-,9-,10-,11+,12+,13+,14+,15+,16-,17-,18-,19-,20-,21-,22+,23+,24+,25+/m1/s1 | Synonyms: | thio-linked xylopentaose | Definition date: | 2008-06-18 | Last modified: | 2020-07-17 | Identifier: | beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranose |
|
![GLO GLO](https://data.pdbj.org/pdbjplus/data/cc/svg/GLO.svg) | GLO | Name: | D-glucose | Formula: | C6 H12 O6 | SMILES: | O=CC(O)C(O)C(O)C(O)CO | InChi: | InChI=1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6+/m0/s1 | Synonyms: | D-GLUCOSE IN LINEAR FORM | Definition date: | 1999-07-08 | Last modified: | 2020-07-17 | Identifier: | D-glucose |
|
![JAG JAG](https://data.pdbj.org/pdbjplus/data/cc/svg/JAG.svg) | JAG | Name: | 2-methyl-3-[4-[4-(trifluoromethyloxy)phenoxy]phenyl]-5,6,7,8-tetrahydro-3~{H}-quinolin-4-one | Formula: | C23 H20 F3 N O3 | SMILES: | CC1=NC2=C(CCCC2)C(=O)[CH]1c3ccc(Oc4ccc(OC(F)(F)F)cc4)cc3 | InChi: | InChI=1S/C23H20F3NO3/c1-14-21(22(28)19-4-2-3-5-20(19)27-14)15-6-8-16(9-7-15)29-17-10-12-18(13-11-17)30-23(24,25)26/h6-13,21H,2-5H2,1H3/t21-/m1/s1 | Definition date: | 2019-01-30 | Last modified: | 2020-07-17 | Release date: | 2020-07-22 | Identifier: | 2-methyl-3-[4-[4-(trifluoromethyloxy)phenoxy]phenyl]-5,6,7,8-tetrahydro-3~{H}-quinolin-4-one |
|
![OBQ OBQ](https://data.pdbj.org/pdbjplus/data/cc/svg/OBQ.svg) | OBQ | Name: | (3~{S})-7-azanyl-6-methoxy-3-[(5~{R})-4-methoxy-6-methyl-7,8-dihydro-5~{H}-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3~{H}-2-benzofuran-1-one | Formula: | C21 H22 N2 O6 | SMILES: | COc1ccc2[CH](OC(=O)c2c1N)[CH]3N(C)CCc4cc5OCOc5c(OC)c34 | InChi: | InChI=1S/C21H22N2O6/c1-23-7-6-10-8-13-19(28-9-27-13)20(26-3)14(10)17(23)18-11-4-5-12(25-2)16(22)15(11)21(24)29-18/h4-5,8,17-18H,6-7,9,22H2,1-3H3/t17-,18+/m1/s1 | Definition date: | 2020-02-26 | Last modified: | 2020-07-17 | Release date: | 2020-07-22 | Identifier: | (3~{S})-7-azanyl-6-methoxy-3-[(5~{R})-4-methoxy-6-methyl-7,8-dihydro-5~{H}-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3~{H}-2-benzofuran-1-one |
|
![OWD OWD](https://data.pdbj.org/pdbjplus/data/cc/svg/OWD.svg) | OWD | Name: | {4-[(6-chloroquinoxalin-2-yl)oxy]phenyl}acetic acid | Formula: | C16 H11 Cl N2 O3 | SMILES: | c2(cnc1cc(Cl)ccc1n2)Oc3ccc(CC(O)=O)cc3 | InChi: | InChI=1S/C16H11ClN2O3/c17-11-3-6-13-14(8-11)18-9-15(19-13)22-12-4-1-10(2-5-12)7-16(20)21/h1-6,8-9H,7H2,(H,20,21) | Definition date: | 2019-07-12 | Last modified: | 2020-07-17 | Release date: | 2020-07-22 | Identifier: | {4-[(6-chloroquinoxalin-2-yl)oxy]phenyl}acetic acid |
|
![OWN OWN](https://data.pdbj.org/pdbjplus/data/cc/svg/OWN.svg) | OWN | Name: | methyl 4-(cyclopropylmethyl)-1-prop-2-enoyl-2,3-dihydroquinoxaline-6-carboxylate | Formula: | C17 H20 N2 O3 | SMILES: | COC(=O)c1ccc2N(CCN(CC3CC3)c2c1)C(=O)C=C | InChi: | InChI=1S/C17H20N2O3/c1-3-16(20)19-9-8-18(11-12-4-5-12)15-10-13(17(21)22-2)6-7-14(15)19/h3,6-7,10,12H,1,4-5,8-9,11H2,2H3 | Definition date: | 2020-04-06 | Last modified: | 2020-07-17 | Release date: | 2020-07-22 | Identifier: | methyl 4-(cyclopropylmethyl)-1-prop-2-enoyl-2,3-dihydroquinoxaline-6-carboxylate |
|
![OY2 OY2](https://data.pdbj.org/pdbjplus/data/cc/svg/OY2.svg) | OY2 | Name: | methyl 4-ethyl-1-propanoyl-2,3-dihydroquinoxaline-6-carboxylate | Formula: | C15 H20 N2 O3 | SMILES: | CCN1CCN(C(=O)CC)c2ccc(cc12)C(=O)OC | InChi: | InChI=1S/C15H20N2O3/c1-4-14(18)17-9-8-16(5-2)13-10-11(15(19)20-3)6-7-12(13)17/h6-7,10H,4-5,8-9H2,1-3H3 | Definition date: | 2020-04-07 | Last modified: | 2020-07-17 | Release date: | 2020-07-22 | Identifier: | methyl 4-ethyl-1-propanoyl-2,3-dihydroquinoxaline-6-carboxylate |
|
![BS7 BS7](https://data.pdbj.org/pdbjplus/data/cc/svg/BS7.svg) | BS7 | Name: | 8-hydroxyquinoline beta-galactopyranoside | Formula: | C15 H17 N O6 | SMILES: | C3(C(C(Oc2c1c(cccn1)ccc2)OC(C3O)CO)O)O | InChi: | InChI=1S/C15H17NO6/c17-7-10-12(18)13(19)14(20)15(22-10)21-9-5-1-3-8-4-2-6-16-11(8)9/h1-6,10,12-15,17-20H,7H2/t10-,12+,13+,14-,15-/m1/s1 | Synonyms: | quinolin-8-yl beta-D-galactopyranoside | Definition date: | 2017-08-23 | Last modified: | 2020-07-17 | Release date: | 2018-02-28 | Identifier: | quinolin-8-yl beta-D-galactopyranoside |
|
![TNJ TNJ](https://data.pdbj.org/pdbjplus/data/cc/svg/TNJ.svg) | TNJ | Name: | 7-[(1S,5R)-1-amino-3-azabicyclo[3.1.0]hexan-3-yl]-4-(aminomethyl)-1-cyclopropyl-3,6-difluoro-8-methylquinolin-2(1H)-one | Formula: | C19 H22 F2 N4 O | SMILES: | c3(C)c2N(C1CC1)C(=O)C(=C(c2cc(c3N5CC4CC4(C5)N)F)CN)F | InChi: | InChI=1S/C19H22F2N4O/c1-9-16-12(13(6-22)15(21)18(26)25(16)11-2-3-11)4-14(20)17(9)24-7-10-5-19(10,23)8-24/h4,10-11H,2-3,5-8,22-23H2,1H3/t10-,19-/m1/s1 | Definition date: | 2020-03-25 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 7-[(1S,5R)-1-amino-3-azabicyclo[3.1.0]hexan-3-yl]-4-(aminomethyl)-1-cyclopropyl-3,6-difluoro-8-methylquinolin-2(1H)-one |
|
![K8N K8N](https://data.pdbj.org/pdbjplus/data/cc/svg/K8N.svg) | K8N | Name: | (1~{S},2~{R},3~{S},5~{R})-3-[2-(2-azanyl-3-bromanyl-quinolin-7-yl)ethyl]-5-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)cyclop
entane-1,2-diol | Formula: | C22 H23 Br N6 O2 | SMILES: | Nc1nc2cc(CC[CH]3C[CH]([CH](O)[CH]3O)n4ccc5c(N)ncnc45)ccc2cc1Br | InChi: | InChI=1S/C22H23BrN6O2/c23-15-8-12-3-1-11(7-16(12)28-21(15)25)2-4-13-9-17(19(31)18(13)30)29-6-5-14-20(24)26-10-27-22(14)29/h1,3,5-8,10,13,17-19,30-31H,2,4,9H2,(H2,25,28)(H2,24,26,27)/t13-,17+,18+,19-/m0/s1 | Synonyms: | JNJ45031882 | Definition date: | 2019-05-02 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (1~{S},2~{R},3~{S},5~{R})-3-[2-(2-azanyl-3-bromanyl-quinolin-7-yl)ethyl]-5-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol |
|
![OUQ OUQ](https://data.pdbj.org/pdbjplus/data/cc/svg/OUQ.svg) | OUQ | Name: | (2~{R})-2-(3-fluorophenyl)-5,5-dimethyl-morpholine | Formula: | C12 H16 F N O | SMILES: | CC1(C)CO[CH](CN1)c2cccc(F)c2 | InChi: | InChI=1S/C12H16FNO/c1-12(2)8-15-11(7-14-12)9-4-3-5-10(13)6-9/h3-6,11,14H,7-8H2,1-2H3/t11-/m0/s1 | Definition date: | 2020-04-06 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (2~{R})-2-(3-fluorophenyl)-5,5-dimethyl-morpholine |
|
![OUZ OUZ](https://data.pdbj.org/pdbjplus/data/cc/svg/OUZ.svg) | OUZ | Name: | ~{N}-ethyl-2-[(2~{S},5~{R})-5-methyl-2-phenyl-morpholin-4-yl]ethanamine | Formula: | C15 H24 N2 O | SMILES: | CCNCCN1C[CH](OC[CH]1C)c2ccccc2 | InChi: | InChI=1S/C15H24N2O/c1-3-16-9-10-17-11-15(18-12-13(17)2)14-7-5-4-6-8-14/h4-8,13,15-16H,3,9-12H2,1-2H3/t13-,15-/m1/s1 | Definition date: | 2020-04-06 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | ~{N}-ethyl-2-[(2~{S},5~{R})-5-methyl-2-phenyl-morpholin-4-yl]ethanamine |
|
![OWZ OWZ](https://data.pdbj.org/pdbjplus/data/cc/svg/OWZ.svg) | OWZ | Name: | (2~{R},5~{S})-2-(2-chlorophenyl)-5-methyl-morpholine | Formula: | C11 H14 Cl N O | SMILES: | C[CH]1CO[CH](CN1)c2ccccc2Cl | InChi: | InChI=1S/C11H14ClNO/c1-8-7-14-11(6-13-8)9-4-2-3-5-10(9)12/h2-5,8,11,13H,6-7H2,1H3/t8-,11-/m0/s1 | Definition date: | 2020-04-06 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (2~{R},5~{S})-2-(2-chlorophenyl)-5-methyl-morpholine |
|
![OXB OXB](https://data.pdbj.org/pdbjplus/data/cc/svg/OXB.svg) | OXB | Name: | 3-[(2~{R},5~{S})-2-(2,5-dimethylphenyl)-5-methyl-morpholin-4-yl]propane-1-sulfonamide | Formula: | C16 H26 N2 O3 S | SMILES: | C[CH]1CO[CH](CN1CCC[S](N)(=O)=O)c2cc(C)ccc2C | InChi: | InChI=1S/C16H26N2O3S/c1-12-5-6-13(2)15(9-12)16-10-18(14(3)11-21-16)7-4-8-22(17,19)20/h5-6,9,14,16H,4,7-8,10-11H2,1-3H3,(H2,17,19,20)/t14-,16-/m0/s1 | Definition date: | 2020-04-07 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 3-[(2~{R},5~{S})-2-(2,5-dimethylphenyl)-5-methyl-morpholin-4-yl]propane-1-sulfonamide |
|
![P0N P0N](https://data.pdbj.org/pdbjplus/data/cc/svg/P0N.svg) | P0N | Name: | (2~{R})-2-(2-chlorophenyl)-5,5-dimethyl-morpholine | Formula: | C12 H16 Cl N O | SMILES: | CC1(C)CO[CH](CN1)c2ccccc2Cl | InChi: | InChI=1S/C12H16ClNO/c1-12(2)8-15-11(7-14-12)9-5-3-4-6-10(9)13/h3-6,11,14H,7-8H2,1-2H3/t11-/m0/s1 | Definition date: | 2020-04-14 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (2~{R})-2-(2-chlorophenyl)-5,5-dimethyl-morpholine |
|
![P0Q P0Q](https://data.pdbj.org/pdbjplus/data/cc/svg/P0Q.svg) | P0Q | Name: | (2~{R},3~{R})-2-(3-chlorophenyl)-3,5,5-trimethyl-morpholine | Formula: | C13 H18 Cl N O | SMILES: | C[CH]1NC(C)(C)CO[CH]1c2cccc(Cl)c2 | InChi: | InChI=1S/C13H18ClNO/c1-9-12(16-8-13(2,3)15-9)10-5-4-6-11(14)7-10/h4-7,9,12,15H,8H2,1-3H3/t9-,12+/m1/s1 | Definition date: | 2020-04-14 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (2~{R},3~{R})-2-(3-chlorophenyl)-3,5,5-trimethyl-morpholine |
|
![P0Z P0Z](https://data.pdbj.org/pdbjplus/data/cc/svg/P0Z.svg) | P0Z | Name: | 3-[(2~{R})-5,5-dimethyl-2-phenyl-morpholin-4-yl]-~{N}-(methylcarbamoyl)propanamide | Formula: | C17 H25 N3 O3 | SMILES: | CNC(=O)NC(=O)CCN1C[CH](OCC1(C)C)c2ccccc2 | InChi: | InChI=1S/C17H25N3O3/c1-17(2)12-23-14(13-7-5-4-6-8-13)11-20(17)10-9-15(21)19-16(22)18-3/h4-8,14H,9-12H2,1-3H3,(H2,18,19,21,22)/t14-/m0/s1 | Definition date: | 2020-04-14 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 3-[(2~{R})-5,5-dimethyl-2-phenyl-morpholin-4-yl]-~{N}-(methylcarbamoyl)propanamide |
|
![P1Q P1Q](https://data.pdbj.org/pdbjplus/data/cc/svg/P1Q.svg) | P1Q | Name: | 1-[(2~{R},5~{S})-2-(3-chlorophenyl)-5-methyl-morpholin-4-yl]-3-methoxy-propan-2-ol | Formula: | C15 H22 Cl N O3 | SMILES: | COCC(O)CN1C[CH](OC[CH]1C)c2cccc(Cl)c2 | InChi: | InChI=1S/C15H22ClNO3/c1-11-9-20-15(12-4-3-5-13(16)6-12)8-17(11)7-14(18)10-19-2/h3-6,11,14-15,18H,7-10H2,1-2H3/t11-,14?,15-/m0/s1 | Definition date: | 2020-04-14 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 1-[(2~{R},5~{S})-2-(3-chlorophenyl)-5-methyl-morpholin-4-yl]-3-methoxy-propan-2-ol |
|
![QGM QGM](https://data.pdbj.org/pdbjplus/data/cc/svg/QGM.svg) | QGM | Name: | (2R,4S)-5,7-dichloro-4-[(phenylcarbamoyl)amino]-1,2,3,4-tetrahydroquinoline-2-carboxylic acid | Formula: | C17 H15 Cl2 N3 O3 | SMILES: | N1c3c(C(CC1C(O)=O)NC(Nc2ccccc2)=O)c(cc(c3)Cl)Cl | InChi: | InChI=1S/C17H15Cl2N3O3/c18-9-6-11(19)15-12(7-9)21-14(16(23)24)8-13(15)22-17(25)20-10-4-2-1-3-5-10/h1-7,13-14,21H,8H2,(H,23,24)(H2,20,22,25)/t13-,14+/m0/s1 | Definition date: | 2019-10-29 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (2R,4S)-5,7-dichloro-4-[(phenylcarbamoyl)amino]-1,2,3,4-tetrahydroquinoline-2-carboxylic acid |
|
![KHK KHK](https://data.pdbj.org/pdbjplus/data/cc/svg/KHK.svg) | KHK | Name: | Ruthenium (bis-(phenanthroline)) (11-nitro-dipyridophenazine) | Formula: | C42 H25 N9 O2 Ru | SMILES: | [Ru].O=[N](=O)c1ccc2nc3c4cccnc4c5ncccc5c3nc2c1.c6cnc7c(c6)ccc8cccnc78.c9cnc%10c(c9)ccc%11cccnc%10%11 | InChi: | InChI=1S/C18H9N5O2.2C12H8N2.Ru/c24-23(25)10-5-6-13-14(9-10)22-18-12-4-2-8-20-16(12)15-11(17(18)21-13)3-1-7-19-15 | Definition date: | 2019-05-22 | Last modified: | 2020-07-03 | Release date: | 2020-07-08 |
|